J.C. Penney Leads These Stocks to 52-Week Highs as S&P Remains Above 1,315
J.C. Penney Company (NYSE:JCP): BMO Capital believes J.C. Penney’s valuation reflects more improvement in sales and earnings than what is achievable and sees several fundamental headwinds. Price target lowered to $29 from $36. The shares closed at $41.42, up $0.7 or 1.72% on the day. They have traded in a 52-week range of $23.44 to $41.24.
Kla-Tencor Corp. (NASDAQ:KLAC): Sees Q3 revenue $770M-$830M vs. consensus $684.04M. Sees Q3 new orders $825M-$975M. Guidance taken from company’s Q2 earnings conference call. The shares closed at $52.33, up $2.07 or 4.12% on the day. They have traded in a 52-week range of $33.20 to $52.11.
Parametric Technolog (NASDAQ:PMTC): Stifel Nicolaus increased its target on Parametric after the company reported Q1 results that the firm views as strong. The firm believes that the company’s outlook is improving, and it maintains a Buy rating. The shares closed at $25.80, up $0.16 or 0.62% on the day. They have traded in a 52-week range of $14.25 to $26.48.
Qlogic Corp. (NASDAQ:QLGC): ThinkEquity upgraded QLogic based on the strong Q3 report, an improving operating model, easing comps, and product refresh. Price target raised to $22 from $15. The shares closed at $17.55, up $0.5 or 2.93% on the day. They have traded in a 52-week range of $11.95 to $18.83.
Regeneron Pharmaceut (NASDAQ:REGN): Roth Capital downgraded Regeneron based on valuation. Price target is $78. The shares closed at $85.54, up $3.69 or 4.51% on the day. They have traded in a 52-week range of $33.36 to $83.40.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at email@example.com
To contact the editor responsible for this story: Damien Hoffman at firstname.lastname@example.org